New cancer clinical trial: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)

Published on: January 31, 2019 at 12:00PM
Conditions:   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urothelial Carcinoma;   High Grade Serous Carcinoma;   Endometrioid Adenocarcinoma;   Urothelial Carcinoma Bladder;   Urothelial Carcinoma Ureter Regional;   Urothelial Carcinoma Ureter Metastatic;   Urothelial Carcinoma Ureter Local;   Urothelial Carcinoma Bladder Recurrent;   Urothelial Carcinoma of the Renal Pelvis and Ureter;   Urothelial Carcinoma Ureter
Interventions:   Drug: Rucaparib;   Drug: Nivolumab
Sponsors:   Clovis Oncology, Inc.;   Bristol-Myers Squibb;   Foundation Medicine
Not yet recruiting
http://bit.ly/2TsaSHu